USE OF CONVALESCENT PLASMA COLLECTED FROM EBOLA VIRUS DISEASE (EVD) SURVIVORS TREATED WITH INTERCEPT BLOOD SYSTEM FOR PATHOGEN INACTIVATION (PI) TO FACILITATE PASSIVE IMMUNE THERAPY

¹Scientific Affairs, Cerus Corp., Concord, California ²Department of Pathology & Laboratory Medicine, Emory University, Atlanta, Georgia ³Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska ⁴Deployment, Cerus Corp., Concord, California ⁵Clinical, Cerus Corp., Concord, California